What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Immune system
- Gene
Gerd-Rüdiger Burmester spends much of his time researching Immunology, Rheumatoid arthritis, Internal medicine, Rheumatology and Tissue engineering.
The Rheumatoid arthritis study combines topics in areas such as Intensive care medicine, Rheumatism, Disease and Arthritis.
His research on Internal medicine frequently links to adjacent areas such as Surgery.
Gerd-Rüdiger Burmester has researched Surgery in several fields, including Odds ratio, Placebo and Logistic regression.
The various areas that he examines in his Rheumatology study include Orthopedic surgery and Cohort study.
Gerd-Rüdiger Burmester has included themes like Biomaterial, Chondrocyte, Matrix and Transplantation in his Tissue engineering study.
His most cited work include:
- Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy : Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks (1376 citations)
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs (1282 citations)
- Arthritis of the finger joints: a comprehensive approach comparing conventional radiography, scintigraphy, ultrasound, and contrast-enhanced magnetic resonance imaging. (554 citations)
What are the main themes of his work throughout his whole career to date?
Immunology, Internal medicine, Rheumatoid arthritis, Arthritis and Rheumatology are his primary areas of study.
His study in Autoantibody, Immune system, Antibody, Antigen and Inflammation is carried out as part of his Immunology studies.
His studies examine the connections between Autoantibody and genetics, as well as such issues in Pathology, with regards to Chondrocyte.
In the field of Internal medicine, his study on Clinical trial overlaps with subjects such as In patient.
Tocilizumab is closely connected to Adverse effect in his research, which is encompassed under the umbrella topic of Rheumatoid arthritis.
As part of the same scientific family, Gerd-Rüdiger Burmester usually focuses on Endocrinology, concentrating on Peripheral blood mononuclear cell and intersecting with Glucocorticoid.
He most often published in these fields:
- Immunology (50.19%)
- Internal medicine (34.10%)
- Rheumatoid arthritis (27.97%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (34.10%)
- Immunology (50.19%)
- Rheumatoid arthritis (27.97%)
In recent papers he was focusing on the following fields of study:
Gerd-Rüdiger Burmester spends much of his time researching Internal medicine, Immunology, Rheumatoid arthritis, Arthritis and In patient.
In general Internal medicine, his work in Adverse effect, Rheumatology, Adalimumab and Clinical trial is often linked to Sarilumab linking many areas of study.
His biological study spans a wide range of topics, including Methotrexate, Surgery and Combination therapy, Pharmacology.
Immunology is often connected to Lupus nephritis in his work.
His Rheumatoid arthritis study combines topics from a wide range of disciplines, such as Factor XIII and Fibrinogen.
The study incorporates disciplines such as Rituximab, Monoclonal, Mesenchymal stem cell, Cell biology and Lactate dehydrogenase A in addition to Arthritis.
Between 2015 and 2021, his most popular works were:
- Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus (173 citations)
- Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study (78 citations)
- Targeting GM-CSF in rheumatoid arthritis. (32 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Immune system
- Gene
Gerd-Rüdiger Burmester mainly investigates Internal medicine, Rheumatoid arthritis, Immunology, Rheumatology and Autoantibody.
His Internal medicine research includes themes of Gastroenterology and Surgery.
His work on Adalimumab and TNF inhibitor as part of general Rheumatoid arthritis study is frequently connected to In patient, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His study in Peripheral blood mononuclear cell extends to Immunology with its themes.
His Rheumatology research incorporates themes from Therapy management and Family medicine.
His work in Autoantibody addresses subjects such as Antigen, which are connected to disciplines such as Antibody, Vimentin, Serology and Anti-dsDNA antibodies.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
